- Home
- MGRX vs TRIB Comparison
MGRX vs TRIB Comparison
Compare MGRX & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MGRX | TRIB |
|---|---|---|
| Founded | 2021 | 1992 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 18.3M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | MGRX | TRIB |
|---|---|---|
| Price | $1.13 | $1.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 502.1K | 83.5K |
| Earning Date | 11-14-2025 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $466,908.00 | ★ $61,555,000.00 |
| Revenue This Year | N/A | $13.51 |
| Revenue Next Year | N/A | $13.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 8.31 |
| 52 Week Low | $0.98 | $0.48 |
| 52 Week High | $6.15 | $3.44 |
Technical Indicators
Market Signals| Indicator | MGRX | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 56.07 |
| Support Level | $1.07 | $1.04 |
| Resistance Level | $1.25 | $1.22 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 54.82 | 59.97 |
Price Performance
Historical ComparisonAbout MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.